Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,978 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not Yet Recruiting

PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma

NCT07207785

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" - IRST S.R.L. - Ematologia Meldola, Forlì-Cesena, Italy
  • Istituto Clinico Humanitas - U.O. Ematologia Rozzano, Milano, Italy
  • AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy
  • Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy
View all 20 locations
View Trial Details
Not Yet Recruiting

Chemotherapy Combined With Targeted Therapy as First-line Treatment for Mantle Cell Lymphoma Based on MRD and PET-CT Assessment

NCT07206264

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Fujian Provincial Cancer Hospital Fuzhou, Fujian, China
  • Hebei Medical University Tumor Hospital Shijiazhuang, Hebei, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Shandong Cancer Hospital Jinan, Shandong, China
View Trial Details
Not Yet Recruiting

Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma

NCT07187960

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Gansu Provincial Hospital Lanzhou, Gansu, China
  • Sun Yet-Sen University Cancer Certer Guangzhou, Guangdong, China
View all 28 locations
View Trial Details

Related conditions